The Food and Drug Administration has approved a supplemental new drug application related to a drug made by Abbott, the company said.
Orbit gum has teamed up with a nonprofit breast cancer prevention organization to encourage young women to be proactive about their breast health.
Icagen officially is a wholly owned subsidiary of Pfizer.
Drug makers Bristol-Myers Squibb and Gilead Sciences announced an agreement to develop and commercialize a fixed-dose combination treatment for patients with HIV.
Pharmaceutical wholesaler H. D. Smith announced on Thursday that Dave Watkins, CFO, will leave the company to join Chicago Public Schools as its new CFO, effective Nov. 7.
An experimental vaccine for hepatitis B made by Dynavax Technologies appears to work better in patients with diabetes than current treatments, the company said.
Procter & Gamble delivered “strong” first-quarter sales growth, kicking off a “good start to the fiscal year” as net sales climbed 9% and organic sales grew 4%, the company announced on Thursday.
Colgate-Palmolive announced on Thursday that it experienced a boost in third-quarter sales and net income as its global market shares in toothpaste and manual toothbrushes both hit record highs year to date.
Revlon announced on Thursday an upswing in third-quarter net sales due in part to higher sales of Revlon color cosmetics and Revlon ColorSilk hair color.
Mylan has received final approval from the Food and Drug Administration for a drug designed to treat moderate to severe pain.